Skip to content

The Effect of Inspiratory muscle training in patients with COVID-19

The Effect of Inspiratory muscle training in quality of life, aerobic capacity and pulmonary functional index in patients with COVID-19 in Masih-Daneshvari hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200611047727N1
Enrollment
40
Registered
2020-06-24
Start date
2020-07-22
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: In this group, patients are taught to perform breathing exercises for four weeks with the help of the respiratory muscle strengthening device. This device is design

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: All male and female patients who have undergone the course of Qovid 19 disease and have referred to the follow-up clinic of Masih Daneshvari Hospital. The age of the clients is between 20 and 60 years Negative PCR Test (Rt: - PCR) Hospital discharge according to the national discharge protocol Lack of oxygen dependence The time between one week and 10 days has passed since the quarantine period Absence of any underlying disease including COPD, CHF and neuromuscular disease or motor disorders PIMAX less than 60%

Exclusion criteria

Exclusion criteria: With any of the experts or unwillingness to continue participating in the project

Design outcomes

Primary

MeasureTime frame
Strenght Index. Timepoint: The first day and four weeks later. Method of measurement: Inspratory muscle traning.

Secondary

MeasureTime frame
Walking distance test six minutes. Timepoint: At the beginning of the study (before the intervention begins) and four weeks later. Method of measurement: Strenght Index.;SF12 scale. Timepoint: At the beginning of the study (before the intervention begins) and four weeks later. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mirenayat

Shahid Beheshti University of Medical Sciences

MirenayaT_M@yahoo.com+98 21 2610 5050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026